Investing Profile

Marcos Milla

InvestorVC
Venture Partner at Samsara BioCapital
Photo of Marcos Milla, Venture Partner at Samsara BioCapital
cb
Samsara BioCapital Venture Partner
$10.0M - $100.0M
$25.0M
5
$310.1M
CompanyStageDateRound SizeTotal Raised
Enlaza Therapeutics
Series AApr 2024$100M
SeedOct 2022$61M
$160M
Co-investors: Stephen Squinto (OrbiMed), Jay Lichter (Avalon Ventures), James N. Topper (Frazier Healthcare Partners)
Tentarix Biotherapeutics
Series BSep 2023$35M
Series AOct 2021$50M
$85M
Co-investors: Allyson Tighe (Amplitude VC), Paul Grayson (Versant Ventures), Jerel Davis (Versant Ventures)
ImmunOs Therapeutics
Series BJun 2022$73M
$99M
Co-investors: Miklos Stanek (BackBone Ventures), Michael Baran (Pfizer Venture Investments), Reinhard Ambros, Daniel Vasella